Genmab | GEN - Trade Debtors


Genmab reported DKK1.22B in Trade Debtors for its fiscal quarter ending in June of 2026.





Trade Debtors Change Date
Agios Pharmaceuticals USD 16.13M 5.56M Mar/2026
Almirall EUR 196.15M 20.22M Jun/2026
Amarin USD 126.83M 477K Dec/2025
Amgen USD 10.23B 1.09B Jun/2026
argenx SE USD 2.01B 352.94M Jun/2026
AstraZeneca USD 18.86B 972M Jun/2026
Bayer EUR 18.7B 146M Jun/2026
BioMarin Pharmaceutical USD 1.06B 157.13M Jun/2026
Demant DKK 5.93B 426M Jun/2026
Exelixis USD 322.21M 6.73M Jun/2026
Fresenius Medical Care EUR 3.47B 250.22M Jun/2026
Genmab DKK 1.22B 192M Jun/2026
GlaxoSmithKline GBP 8.07B 137M Jun/2026
GN Store Nord DKK 2.99B 557M Jun/2026
GRIFOLS EUR 1.19B 231M Jun/2026
Hikma Pharmaceutical USD 1.08B 27M Dec/2025
Insmed USD 215.32M 36.77M Jun/2026
Lakefront Biotherapeutics EUR 149.47M 95.44M Jun/2026
Lonza CHF 1.78B 55M Dec/2025
Merck EUR 4.95B 139M Jun/2026
Novartis USD 9.85B 252M Jun/2026
Regeneron Pharmaceuticals USD 6.57B 834.4M Jun/2026
Roche Holding CHF 13.34B 1.44B Jun/2026
Sanofi EUR 492M 10M Jun/2026
UCB EUR 1.97B 54M Dec/2025